Absence of a significant interaction of two common NOS1 and 5-HTT polymorphisms on sensorimotor gating in humans

. 2021 Dec 31 ; 70 (S3) : S387-S395.

Jazyk angličtina Země Česko Médium print

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/pmid35099257

The neurotransmitter serotonin has been critically implicated in the pathogenesis of several mental disorders. The serotonin transporter (5-HTT) is a key regulator of serotonergic neurotransmission and its genetic variability is associated with increased risk of psychopathology. One well known polymorphic locus in the 5-HTT gene affecting its expression is a tandem repeat in the promoter region (5-HTTLPR). It has been reported that 5-HTT is functionally coupled with the neuronal nitric oxide synthase (NOS1 or nNOS), an enzyme catalyzing the production of nitric oxide (NO). We have previously demonstrated that a tandem repeat polymorphism in the promoter of NOS1 exon 1f (Ex1f-VNTR) is associated with sensorimotor gating, a marker of inhibitory processing and a well established endophenotype of several neuropsychiatric disorders. Here we investigated the combined genetic effects of NOS1 Ex1f-VNTR and 5-HTTLPR on sensorimotor gating, measured by prepulse inhibition (PPI) of the acoustic startle reflex, in 164 healthy adults. We found no evidence for the interaction between NOS1 Ex1f-VNTR and 5-HTTLPR on PPI. PPI was associated with NOS1 Ex1f-VNTR, but not 5-HTTLPR. Our data suggest that while NOS1 plays a role in sensorimotor gating, the nitrergic pathway of gating regulation does not involve the action of 5-HTT.

Zobrazit více v PubMed

ANGUELOVA M, BENKELFAT C, TURECKI G. A systematic review of association studies investigating genes coding for serotonin receptors and the serotonin transporter: I. Affective disorders. Mol Psychiatry. 2003;8:574–591. doi: 10.1038/sj.mp.4001328. PubMed DOI

BAOU M, BOUMBA VA, PETRIKIS P, RALLIS G, VOUGIOUKLAKIS T, MAVREAS V. A review of genetic alterations in the serotonin pathway and their correlation with psychotic diseases and response to atypical antipsychotics. Schizophr Res. 2016;170:18–29. doi: 10.1016/j.schres.2015.11.003. PubMed DOI

BARRETT JC, FRY B, MALLER J, DALY MJ. Haploview: Analysis and visualization of LD and haplotype maps. Bioinformatics. 2005;21:263–265. doi: 10.1093/bioinformatics/bth457. PubMed DOI

BERMINGHAM DP, BLAKELY RD. Kinase-dependent regulation of monoamine neurotransmitter transporters. Pharmacol Rev. 2016;68:888–953. doi: 10.1124/pr.115.012260. PubMed DOI PMC

BRÄUER D, STROBEL A, HENSCH T, DIERS K, LESCH K-P, BROCKE B. Genetic variation of serotonin receptor function affects prepulse inhibition of the startle. J Neural Transm. 2009;116:607–613. doi: 10.1007/s00702-009-0222-0. PubMed DOI

CHANRION B, MANNOURY LA, COUR C, BERTASO F, LERNER-NATOLI M, FREISSMUTH M, MILLAN MJ, BOCKAERT J, MARIN P. Physical interaction between the serotonin transporter and neuronal nitric oxide synthase underlies reciprocal modulation of their activity. Proc Natl Acad Sci U S A. 2007;104:8119–8124. doi: 10.1073/pnas.0610964104. PubMed DOI PMC

CHIAVEGATTO S. Brain serotonin dysfunction accounts for aggression in male mice lacking neuronal nitric oxide synthase. Proc Natl Acad Sci U S A. 2001;98:1277–1281. doi: 10.1073/pnas.031487198. PubMed DOI PMC

CHMELOVA M, BALAGOVA L, MARKO M, VRANKOVA S, CEBOVA M, JEZOVA D, RIECANSKY I, HLAVACOVA N. Behavioral alterations induced by post-weaning isolation rearing of rats are accompanied by reduced VGF/BDNF/TrkB signaling in the hippocampus. Neurochem Int. 2019;129:104473. doi: 10.1016/j.neuint.2019.104473. PubMed DOI

CSOMOR PA, YEE BK, VOLLENWEIDER FX, FELDON J, NICOLET T, QUEDNOW BB. On the influence of baseline startle reactivity on the indexation of prepulse inhibition. Behav Neurosci. 2008;122:885–900. doi: 10.1037/0735-7044.122.4.885. PubMed DOI

DERKSEN M, FEENSTRA M, WILLUHN I, DENYS D. The serotonergic system in obsessive-compulsive disorder. In: MÜLLER CP, JACOBS BL, editors. Handbook of Behavioral Neuroscience. Elsevier B.V; Amsterdam: 2020. pp. 865–891. DOI

FAUL F, ERDFELDER E, LANG A-G, BUCHNER A. G*Power 3: A flexible statistical power analysis program for the social, behavioral, and biomedical sciences. Behav Res Methods. 2007;39:175–191. doi: 10.3758/BF03193146. PubMed DOI

FREUDENBERG F, ALTTOA A, REIF A. Neuronal nitric oxide synthase (NOS1) and its adaptor, NOS1AP, as a genetic risk factors for psychiatric disorders. Genes Brain Behav. 2015;14:46–63. doi: 10.1111/gbb.12193. PubMed DOI

GARTHWAITE J. Neuronal nitric oxide synthase and the serotonin transporter get harmonious. Proc Natl Acad Sci U S A. 2007;104:7739–7740. doi: 10.1073/pnas.0702508104. PubMed DOI PMC

GATT JM, BURTON KLO, WILLIAMS LM, SCHOFIELD PR. Specific and common genes implicated across major mental disorders: A review of meta-analysis studies. J Psychiatr Res. 2015;60:1–13. doi: 10.1016/j.jpsychires.2014.09.014. PubMed DOI

GRESSIER F, CALATI R, BALESTRI M, MARSANO A, ALBERTI S, ANTYPA N, SERRETTI A. The 5-HTTLPR polymorphism and posttraumatic stress disorder: A meta-analysis. J Trauma Stress. 2013;26:645–653. doi: 10.1002/jts.21855. PubMed DOI

HALBERSTADT AL, NICHOLS DE. Serotonin and serotonin receptors in hallucinogen action. In: MÜLLER CP, CUNNINGHAM KA, editors. Handbook of Behavioral Neuroscience. Elsevier B.V; Amsterdam: 2020. pp. 843–863. DOI

HEILS A, TEUFEL A, PETRI S, STÖBER G, RIEDERER P, BENGEL D, LESCH KP. Allelic variation of human serotonin transporter gene expression. J Neurochem. 2002;66:2621–2624. doi: 10.1046/j.1471-4159.1996.66062621.x. PubMed DOI

HOOGMAN M, AARTS E, ZWIERS M, SLAATS-WILLEMSE D, NABER M, ONNINK M, COOLS R, KAN C, BUITELAAR J, FRANKE B. Nitric oxide synthase genotype modulation of impulsivity and ventral striatal activity in adult ADHD patients and healthy comparison subjects. Am J Psychiatry. 2011;168:1099–1106. doi: 10.1176/appi.ajp.2011.10101446. PubMed DOI

JASP Team. JASP (Version 0.14)[Computer software] 2020.

KISS J. Nitric oxide: A novel link between synaptic and nonsynaptic transmission. Trends Neurosci. 2001;24:211–215. doi: 10.1016/S0166-2236(00)01745-8. PubMed DOI

KOHL S, HEEKEREN K, KLOSTERKÖTTER J, KUHN J. Prepulse inhibition in psychiatric disorders - Apart from schizophrenia. J Psychiatr Res. 2013;47:445–452. doi: 10.1016/j.jpsychires.2012.11.018. PubMed DOI

KUMARI V, CHECKLEY SA, GRAY JA. Effect of cigarette smoking on prepulse inhibition of the acoustic startle reflex in healthy male smokers. Psychopharmacology (Berl) 1996;128:54–60. doi: 10.1007/s002130050109. PubMed DOI

LEE MD, WAGENMAKERS E-J. Bayesian Cognitive Modeling: A Practical Course. Cambridge University Press; Cambridge: 2013. Bayesian model comparison; pp. 101–117. DOI

LESCH KP, BENGEL D, HEILS A, SABOL SZ, GREENBERG BD, PETRI S, BENJAMIN J, MÜLLER CR, HAMER DH, MURPHY DL. Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region. Science. 1996;274:1527–1531. doi: 10.1126/science.274.5292.1527. PubMed DOI

LI W, MAO Z, BO Q, SUN Y, WANG Z, WANG C. Prepulse inhibition in first-degree relatives of schizophrenia patients: A systematic review. Early Interv Psychiatry. 2021;15:652–661. doi: 10.1111/eip.13003. PubMed DOI

LIECHTI ME, GEYER MA, HELL D, VOLLENWEIDER FX. Effects of MDMA (ecstasy) on prepulse inhibition and habituation of startle in humans after pretreatment with citalopram, haloperidol, or ketanserin. Neuropsychopharmacology. 2001;24:240–252. doi: 10.1016/S0893-133X(00)00199-8. PubMed DOI

LIGHT GA, BRAFF DL. Human and animal studies of schizophrenia-related gating deficits. Curr Psychiatry Rep. 1999;1:31–40. doi: 10.1007/s11920-999-0008-y. PubMed DOI

LUDEWIG K, LUDEWIG S, SEITZ A, OBRIST M, GEYER MA, VOLLENWEIDER FX. The acoustic startle reflex and its modulation: Effects of age and gender in humans. Biol Psychol. 2003;63:311–323. doi: 10.1016/S0301-0511(03)00074-7. PubMed DOI

MANN C, CROFT RJ, SCHOLES KE, DUNNE A, O’NEILL BV, LEUNG S, COPOLOV D, PHAN KL, NATHAN PJ. Differential effects of acute serotonin and dopamine depletion on prepulse inhibition and P50 suppression measures of sensorimotor and sensory gating in humans. Neuropsychopharmacology. 2008;33:1653–1666. doi: 10.1038/sj.npp.1301556. PubMed DOI

MAURA G, MARCOLI M, PEPICELLI O, ROSU C, VIOLA C, RAITERI M. Serotonin inhibition of the NMDA receptor/nitric oxide/cyclic GMP pathway in human neocortex slices: Involvement of 5-HT(2C) and 5-HT(1A) receptors. Br J Pharmacol. 2000;130:1853–1858. doi: 10.1038/sj.bjp.0703510. PubMed DOI PMC

MOYA PR, WENDLAND JR, RUBENSTEIN LM, TIMPANO KR, HEIMAN GA, TISCHFIELD JA, KING RA, ANDREWS AM, RAMAMOORTHY S, McMAHON FJ, MURPHY DL. Common and rare alleles of the serotonin transporter gene, SLC6A4, associated with Tourette’s disorder. Mov Disord. 2013;28:1263–1270. doi: 10.1002/mds.25460. PubMed DOI PMC

NAKAMURA M, UENO S, SANO A, TANABE H. The human serotonin transporter gene linked polymorphism (5-HTTLPR) shows ten novel allelic variants. Mol Psychiatry. 2000;5:32–38. doi: 10.1038/sj.mp.4000698. PubMed DOI

PITTENGER C, ADAMS TG, GALLEZOT JD, CROWLEY MJ, NABULSI N, JAMES R, GAO H, KICHUK SA, SIMPSON R, BILLINGSLEA E, HANNESTAD J, BLOCH M, MAYES L, BHAGWAGAR Z, CARSON RE. OCD is associated with an altered association between sensorimotor gating and cortical and subcortical 5-HT1b receptor binding. J Affect Disord. 2016;196:87–96. doi: 10.1016/j.jad.2016.02.021. PubMed DOI PMC

QUEDNOW BB, ETTINGER U, MÖSSNER R, RUJESCU D, GIEGLING I, COLLIER DA, SCHMECHTIG A, KÜHN K-U, MÖLLER H-J, MAIER W, WAGNER M, KUMARI V. The schizophrenia risk allele C of the TCF4 rs9960767 polymorphism disrupts sensorimotor gating in schizophrenia spectrum and healthy volunteers. J Neurosci. 2011;31:6684–6691. doi: 10.1523/JNEUROSCI.0526-11.2011. PubMed DOI PMC

QUEDNOW BB, GEYER MA, HALBERSTADT AL. Serotonin and schizophrenia. Handb Behav Neurosci. 2020;31:711–743. doi: 10.1016/B978-0-444-64125-0.00039-6. DOI

QUEDNOW BB, KOMETER M, GEYER MA, VOLLENWEIDER FX. Psilocybin-induced deficits in automatic and controlled inhibition are attenuated by ketanserin in healthy human volunteers. Neuropsychopharmacology. 2012;37:630–640. doi: 10.1038/npp.2011.228. PubMed DOI PMC

RAYMOND JR, MUKHIN YV, GELASCO A, TURNER J, COLLINSWORTH G, GETTYS TW, GREWAL JS, GARNOVSKAYA MN. Multiplicity of mechanisms of serotonin receptor signal transduction. Pharmacol Ther. 2001;92:179–212. doi: 10.1016/S0163-7258(01)00169-3. PubMed DOI

ROVNÝ R, BESTERCIOVÁ D, RIEČANSKÝ I. Genetic determinants of gating functions: Do we get closer to understanding schizophrenia etiopathogenesis? Front Psychiatry. 2020;11:550225. doi: 10.3389/fpsyt.2020.550225. PubMed DOI PMC

ROVNÝ R, MARKO M, KATINA S, MURÍNOVÁ J, ROHÁRIKOVÁ V, CIMROVÁ B, REPISKÁ G, MINÁRIK G, RIEČANSKÝ I. Association between genetic variability of neuronal nitric oxide synthase and sensorimotor gating in humans. Nitric Oxide. 2018;80:32–36. doi: 10.1016/J.NIOX.2018.08.002. PubMed DOI

SERRETTI A, CALATI R, MANDELLI L, De RONCHI D. Serotonin transporter gene variants and behavior: A comprehensive review. Curr Drug Targets. 2006;7:1659–1669. doi: 10.2174/138945006779025419. PubMed DOI

SIPES TA, GEYER MA. Multiple serotonin receptor subtypes modulate prepulse inhibition of the startle response in rats. Neuropharmacology. 1994;33:441–448. doi: 10.1016/0028-3908(94)90074-4. PubMed DOI

SPIES M, KNUDSEN GM, LANZENBERGER R, KASPER S. The serotonin transporter in psychiatric disorders: Insights from PET imaging. Lancet Psychiatry. 2015;2:743–755. doi: 10.1016/S2215-0366(15)00232-1. PubMed DOI

SWERDLOW NR, AUERBACH P, MONROE SM, HARTSTON H, GEYER MA, BRAFF DL. Men are more inhibited than women by weak prepulses. Biol Psychiatry. 1993;34:253–260. doi: 10.1016/0006-3223(93)90079-S. PubMed DOI

SWERDLOW NR, LIGHT GA. Sensorimotor gating deficits in schizophrenia: Advancing our understanding of the phenotype, its neural circuitry and genetic substrates. Schizophr Res. 2018;198:1–5. doi: 10.1016/j.schres.2018.02.042. PubMed DOI PMC

TAYLOR S. Molecular genetics of obsessive-compulsive disorder: A comprehensive meta-analysis of genetic association studies. Mol Psychiatry. 2013;18:799–805. doi: 10.1038/mp.2012.76. PubMed DOI

TOPALOGLU M, TUZUN E, GULEC H, BIRELLER ES, CAKMAKOGLU B, KUCUKALI CI. Neuronal nitric oxide synthase polymorphisms in obsessive-compulsive disorder. Nord J Psychiatry. 2017;71:115–119. doi: 10.1080/08039488.2016.1240230. PubMed DOI

TRIPATHI MK, KARTAWY M, AMAL H. The role of nitric oxide in brain disorders: Autism spectrum disorder and other psychiatric, neurological, and neurodegenerative disorders. Redox Biol. 2020;34:101567. doi: 10.1016/j.redox.2020.101567. PubMed DOI PMC

VRANKOVA S, GALANDAKOVA Z, BENKO J, CEBOVA M, RIECANSKY I, PECHANOVA O. Duration of social isolation affects production of nitric oxide in the rat brain. Int J Mol Sci. 2021;22:10340. doi: 10.3390/ijms221910340. PubMed DOI PMC

WILCOX R. A foundation for robust methods. In: WILCOX R, editor. Introduction to Robust Estimation and Hypothesis Testing. Elsevier; Boston: 2012. pp. 23–s42. DOI

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...